血液系统疾病患者置入中心静脉导管发生血栓相关危险因素的Meta分析

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (2781 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate independent risk factors for peripherally inserted central catheter-related thrombosis (PICC-RT).Methods Literature search of the PubMed, Web of Science, Medline, China National Knowledge Infrastructure, VIP Chinese Science and Technology Periodicals, and Wanfang databases was performed for case control studies investigating patients who experienced PICC-RT, published from database inception to June 2022. Subsequently, two investigators independently screened the retrieved studies for factors influencing PICC-RT according to pre-defined admission and discharge criteria, and evaluated study quality and extracted the relevant data. Review Manager version 5.3 (The Cochrane Collaboration, 2020) was used to perform Meta-analysis on the extracted data to determine risk factors for PICC-RT.Results A total of 14 literatures were included, involving 3127 patients, and 38 influencing factors were analyzed. Patients were divided into study group (n=297) and control group (n=2830) according to whether PICC-RT occurred. According to the results of Meta and statistical analysis, 10 influencing factors with OR≥1 and P≤0.05 were listed as the risk factors for PICC-RT in patients with blood system: age ≥60 years, coinfection, risk stratification as medium-high risk, BMI≥25, ECOG score ≥2, previous surgical history, abnormal PICC catheter tip position, non-tunneling PICC, and platelet level ≥350×10⁹/L, and catheterization time >6 months.Conclusions A total of 10 factors influencing PICC-RT in hematological patients have been found, which may contribute to thrombosis prevention and disease risk stratification.

Key words： blood disease thrombosis peripherally inserted central catheter high risk factors Meta analysis

Received: 14 February 2023

ZTFLH:

R552.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YANG Yakun
	SONG Yan
	ZHAO Jinna
	LIU Juan
	XU Fengrui
	LV Panpan

Cite this article:

YANG Yakun,SONG Yan,ZHAO Jinna等. Meta analysis of risk factors for thrombosis in patients with hematological diseases receiving central venous catheter via peripheral vein puncture[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(9): 799-804.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2023/V34/I9/799

[1]	Gillian R Barruel,Formal A,Methodology,et al. Barriers and facilitators for implementing peripherally inserted central catheter (PICC) appropriateness guidelines: a longitudinal survey study from 34 Michigan hospitals[J]. PLoS One,2022,17(11): e0277302.
[2]	Yan H,Yun L,Yingying Y,et al. Analysis of risk factors of PICC-related bloodstream infection in newborns: implications for nursing care[J]. Eur J Med Res,2021,26:80.
[3]	Sona D, Qinghua Z, Birendra S B. Peripherally inserted central catheters in critically ill patients-complications and its prevention: a review[J]. Int J Nurs Sci,2019,6(1):99105.
[4]	Osamah A, Manar A, Hany E. Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study [J].Thromb J,2019,17(1): 2.
[5]	Lokich J J, Becker B.Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy[J]. Cancer,1983,52:1586-1589.
[6]	Xiaomin S,Hong L,Fang C, et al. A longitudinal observational retrospective study on risk factors and predictive model of PICC associated thrombosis in cancer patients[J]. Sci Rep,2020,10:10090.
[7]	Young M A, Begum G, Billingham J L, et al. A multicentre prospective randomized controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs) [J]. Proc Am Soc Clin Oncol, 2005,23:8004a.
[8]	Mark J L,Bradley S S, Shelby M H, et al. What are the risk factors for an upper extremity deep venous thrombosis after orthopaedic irrigation and debridement and peripherally inserted central catheter placement?[J]. Mo Med,2021,118(4):374-380.
[9]	Yajuan L,Yong H,Bo P,et al. Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis[J].Oncotarget,2018,9(15): 12376-12388.
[10]	魏沄沄,张元元.儿童急性淋巴细胞白血病诱导化疗期导管相关性血栓发病及危险因素分析[J]. 中华血液学杂志,2017,38(4):313-317.
[11]	王枫,孙建,谢辉.急性白血病PICC置管后静脉血栓发生的回顾性分析[J].现代肿瘤医学,2014,22(11):2686-2688.
[12]	沈晶晶. 急性白血病化疗患者PICC相关性血栓影响因素分析及干预措施[J]. 全科医学临床与教育,2020,18(2):173-175.
[13]	徐咏梅,胡桑,程凤,等. 血液肿瘤患者 PICC 置管后并发静脉血栓的原因分析[J].安徽医学,2018,39(9):1146-1148.
[14]	钱玲玲. 恶性血液病导管相关性血栓的回顾性研究[D].南京:南京医科大学,2017.
[15]	郑彩凤. 血液肿瘤患者PICC导管相关静脉血栓的危险因素及预防措施研究[D].广州:广东医科大学,2018.
[16]	刘艳慧,张茵. 血液肿瘤患者PICC相关性静脉血栓临床分析[J]. 血栓与止血,2016,22(4):433-435.
[17]	黎建云,涂传清,彭玲,等. 急性白血病患者经外周静脉穿刺置入中心静脉导管致静脉血栓形成的研究[J].血栓与止血学,2017,23(2):214-217.
[18]	Hong Q, Jin L, Chunyan X,et al. Predisposing factors and effect of bundle nursing in PICC-related upper extremity deep venous thrombosis in patients with non-Hodgkin's lymphoma undergoing chemotherapy[J]. Am J Transl Res, 2021,13(8):9679-9686.
[19]	Priya S, Katharine W, David C,et al. Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients[J]. Thromb J, 2015,13:21.
[20]	Salvatore G M, Roberto L, Corrado G,et al. Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)[J].Support Care Cancer, DOI 10.1007/s00520-015-2740-7.
[21]	Agostino C, Marco M, Anna F, et al. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study[J]. Br J Haematol,2005,129(129): 811-817.
[22]	Tetsuaki B, Shin F, Rui M,et al. Risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia[J]. Intern Med, 2022,61:989-995.
[23]	梁梅菊,张兰兰,葛朋莉. 白血病患者接受PICC置管后DVT发生因素Logistic分析及应用风险管理干预措施的效果研究[J].全科护理 ,2020,8(1): 52-55
[24]	Vineet C, Megan O M, Jennifer H, et al. Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals[J]. BMJ Qual Saf,2022 ,31(1):23-30.
[25]	中国临床肿瘤学会肿瘤与血栓专家共识委员会. 肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版) [J].中国实用内科杂志,2019,46(13):653-660.
[26]	Donati M B. Thrombosis and cancer: 40 years of research[J].Thromb Res,2012, 129(3):348-352.
[27]	Leung T K,Lee C M, Tai C J, et al .Aretrospective study on the long-term placement of peripherally inserted central catheter sand the importance of nursing care and education[J] .Cancer nursing,2011,34(1): E25-E30.
[28]	Xinyu Y, Xiaoye C. The role of type 1 interferons in coagulation induced by gram-negative bacteria[J].Blood,2020,14(135):1087-1100.
[29]	Lobo B L,Vaidean G,Broyles J,et al.Risk of venous throomboembolism in hospitalized patients with peripherally inserted central catheters[J]. J Hosp Med,2009,4(7):417-422.
[30]	Gholamreza B,Pourya S,Ali M A, et al. A review of peripherally inserted central catheters and various types of vascular access in very small children and pediatric patients and their potential complications [J]. J Med Life,2021,14(3): 298-309.
[31]	Marina A T, María A. Rodríguez P,et al. Tunneled catheter-related bacteremia in hemodialysis patients: incidence, risk factors and outcomes. a 14-year observational study[J]. J Nephrol,2023,36(1):203-212.

[1]	. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(6): 517-518.